Aplicación en la práctica clínica de la determinación Prenatal no Invasiva en el Genotipo RhD Fetal Durante el Primer Trimestre de la gestación en Gestantes RhD Negativas
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Prenatal determination fetal RhD genotype
研究概览
简要总结
Actually, our center is doing the prenatal determination of RhD fetal genotype in all RhD negative pregnant women.
The investigator want to demonstrate that this is an useful and efficient method.
详细描述
This is a retrospective observational study that pretend to demonstrate that the prenatal determination of RhD fetal genotype is useful and efficient in our clinical practice.
I'm going to check the clinical history of all negative RhD pregnant women since January 2013 until December 2015.
I'll check if prenatal determination matches with postnatal RhD determination of newborn.
Usually, when a RhD negative woman is pregnant we administrate gammaglobulin in 28 gestation weeks, after invasive procedures and after delivery if the baby is positive RhD.
Althought, the investigators know that the 40 percent of RhD negative pregnant have a negative RhD baby.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Pregnant RhD negative women
排除标准
- •Pregnant RhD positive women
结局指标
主要结局
Prenatal determination fetal RhD genotype
时间窗: Ten months
RhD negative/ RhD positive
次要结局
未报告次要终点